Chemours Announces Board and Executive Changes

Ticker: CC · Form: 8-K · Filed: 2025-08-29T00:00:00.000Z

Sentiment: neutral

Topics: management-change, compensation, governance

Related Tickers: CC

TL;DR

Chemours shakes up its board and exec comp. Big changes coming?

AI Summary

On August 29, 2025, The Chemours Company filed an 8-K report detailing changes in its board of directors and executive compensation. The filing indicates the departure of certain officers and directors, the election of new directors, and updates to compensatory arrangements for key executives. Specific details regarding the individuals involved and the exact nature of the compensatory changes are outlined within the report.

Why It Matters

Changes in a company's board and executive compensation can signal shifts in strategy, governance, or financial outlook, impacting investor confidence and future performance.

Risk Assessment

Risk Level: medium — Changes in leadership and compensation can introduce uncertainty and signal potential strategic shifts, which may carry inherent risks.

Key Players & Entities

FAQ

Who are the specific officers and directors departing from The Chemours Company?

The filing indicates the departure of certain officers and directors, but specific names are not provided in the summary information.

When were the new directors elected to The Chemours Company's board?

The filing reports on the election of new directors as of August 29, 2025.

What are the key changes in the compensatory arrangements for The Chemours Company's officers?

The filing notes updates to compensatory arrangements for certain officers, but the specific details of these changes are not elaborated in the provided summary.

What is the primary reason for the reported changes in directors and officers at Chemours?

The filing does not explicitly state the reason for the departures or appointments, only that these events occurred and are being reported.

Does this 8-K filing include information about The Chemours Company's financial performance?

This specific 8-K filing focuses on the departure of directors, election of directors, appointment of officers, and compensatory arrangements, not financial performance.

From the Filing

0001627223-25-000005.txt : 20250829 0001627223-25-000005.hdr.sgml : 20250829 20250829163335 ACCESSION NUMBER: 0001627223-25-000005 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 11 CONFORMED PERIOD OF REPORT: 20250829 ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers FILED AS OF DATE: 20250829 DATE AS OF CHANGE: 20250829 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Chemours Co CENTRAL INDEX KEY: 0001627223 STANDARD INDUSTRIAL CLASSIFICATION: CHEMICALS & ALLIED PRODUCTS [2800] ORGANIZATION NAME: 08 Industrial Applications and Services EIN: 464845564 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-36794 FILM NUMBER: 251281433 BUSINESS ADDRESS: STREET 1: 1007 MARKET STREET CITY: WILMINGTON STATE: DE ZIP: 19801 BUSINESS PHONE: 302 773 1000 MAIL ADDRESS: STREET 1: 1007 MARKET STREET CITY: WILMINGTON STATE: DE ZIP: 19801 FORMER COMPANY: FORMER CONFORMED NAME: Chemours Company, LLC DATE OF NAME CHANGE: 20141205 8-K 1 cc-20250829.htm 8-K 8-K 0001627223 false 0001627223 2025-08-29 2025-08-29     UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549   FORM 8-K   CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934   August 29, 2025 Date of Report (Date of Earliest Event Reported) The Chemours Company (Exact Name of Registrant as Specified in Its Charter)   Delaware   001-36794   46-4845564 (State or Other Jurisdiction   (Commission   (I.R.S. Employer Of Incorporation)   File Number)   Identification No.)   1007 Market Street Wilmington , Delaware 19801 (Address of principal executive offices)   Registrant’s telephone number, including area code: (302) 773-1000   Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:   ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))   Securities registered pursuant to Section 12(b) of the Act:   Title of Each Class   Trading Symbol(s)   Name of Exchange on Which Registered Common Stock ($0.01 par value)   CC   New York Stock Exchange   Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company   ☐   If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.   ☐           Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.   On August 29, 2025, Dawn Farrell, Chair of the Board of Directors (the “Board”) of The Chemours Company (the “Company”), notified the Board of her decision to resign from the Board effective September 2, 2025, to accept an appointment with the Canadian government as Chief Executive Officer of the newly created Major Projects Office launched by the Prime Minister of Canada under the Building Canada Act . As the Board received notice on August 29th of Mrs. Farrell’s appoint

View on Read The Filing